Literature DB >> 6026121

Enuresis and nocturia in sickle cell disease.

J B Noll, A J Newman, S Gross.   

Abstract

Entities:  

Mesh：

Year:  1967        PMID： 6026121     DOI： 10.1016/s0022-3476(67)80273-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Overactive bladder in adults with sickle cell disease.

Authors:  Uzoma A Anele; Belinda F Morrison; Marvin E Reid; Wendy Madden; Shara Foster; Arthur L Burnett
Journal:  Neurourol Urodyn       Date:  2015-04-14       Impact factor: 2.696

2.  Enuresis is a common and persistent problem among children and young adults with sickle cell anemia.

Authors:  Joshua J Field; Paul F Austin; Ping An; Yan Yan; Michael R DeBaun
Journal:  Urology       Date:  2008-04-02       Impact factor: 2.649

3.  Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG).

Authors:  Scott T Miller; Winfred C Wang; Rathi Iyer; Sohail Rana; Peter Lane; Russell E Ware; Daner Li; Renée C Rees
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

4.  Enuresis associated with sleep disordered breathing in children with sickle cell anemia.

Authors:  Gloria C Lehmann; Teal R Bell; Fenella J Kirkham; Johanna C Gavlak; Tekeda F Ferguson; Robert C Strunk; Paul Austin; Carol L Rosen; Melanie J Marshall; Olu Wilkey; Mark J Rodeghier; John O Warner; Michael R DeBaun
Journal:  J Urol       Date:  2012-08-19       Impact factor: 7.450

5.  Prevalence of enuresis and its impact in quality of life of patients with sickle cell disease.

Authors:  Alana de Medeiros Nelli; Flavia Cristina de Carvalho Mrad; Mateus de Andrade Alvaia; Heros Aureliano Antunes da Silva Maia; Carina Oliveira Silva Guimarães; Evanilda Souza de Santana Carvalho; Cristiano Mendes Gomes; José Murillo Bastos; Jose de Bessa
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 3.050
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.